Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Reducing Reliance on China for Rare Earths Production and Processing

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Can You Invest in Elon Musk’s Neuralink? (Updated 2024)

Rick Rule: Gold, Silver, Uranium — Key Price Drivers and What to Watch Now

A State-by-State Guide to Cannabis in Australia (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Rare Earths Stocks: 9 Biggest Companies in 2024

Top 10 Copper-producing Companies (Updated 2024)

Trending Press Releases

Corporate Update

Grid Battery Metals and AC/DC Battery Metals Announces Update of Listing of AC/DC Shares on the TSXV and Financing Details

Blue Sky Uranium Launches Strategic Exploration Program for In-Situ Recovery Uranium Targets in Argentina with Two New Project Acquisitions

Ramp Metals Announces New High-Grade Gold Discovery of 73.55 g/t Au over 7.5m at its Rottenstone SW Project

Radiopharm Receives Strategic Investment for up to A$18 million

Sarama Signs MOU Over West Australian Gold Project

More Press Releases
Trending Companies

Galan Lithium

GLN:AU

Cardiol Therapeutics

CRDL:CA

EMU NL

EMU:AU

Horizon Minerals

HRZ:AU
More Companies
Trending Reports

2024 Gold Outlook Report

2024 Lithium Market Outlook (Updated for Q2)

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Copper Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Silverback Therapeutics Inc.

NASDAQ:SBTX
Press Releases

ARS Pharmaceuticals Submits Response for neffy® Marketing Authorization Application to EMA's CHMP and Enters License Agreement with CSL Seqirus for Commercialization of neffy in Australia and New Zealand

Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

Interactive Chart

×